Product NDC: | 54569-4736 |
Proprietary Name: | SINGULAIR |
Non Proprietary Name: | montelukast sodium |
Active Ingredient(s): | 5 mg/1 & nbsp; montelukast sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, CHEWABLE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54569-4736 |
Labeler Name: | A-S Medication Solutions LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020830 |
Marketing Category: | NDA |
Start Marketing Date: | 20001110 |
Package NDC: | 54569-4736-0 |
Package Description: | 30 TABLET, CHEWABLE in 1 BOTTLE, DISPENSING (54569-4736-0) |
NDC Code | 54569-4736-0 |
Proprietary Name | SINGULAIR |
Package Description | 30 TABLET, CHEWABLE in 1 BOTTLE, DISPENSING (54569-4736-0) |
Product NDC | 54569-4736 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | montelukast sodium |
Dosage Form Name | TABLET, CHEWABLE |
Route Name | ORAL |
Start Marketing Date | 20001110 |
Marketing Category Name | NDA |
Labeler Name | A-S Medication Solutions LLC |
Substance Name | MONTELUKAST SODIUM |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA] |